Showing posts sorted by relevance for query VACCINATION. Sort by date Show all posts
Showing posts sorted by relevance for query VACCINATION. Sort by date Show all posts

Saturday, May 16, 2020

Lessons We Can Learn from Mandatory Vaccine Policies in Europe
Lewis First, MD, MS, Editor in Chief, Pediatrics
J
anuary 16, 2020


We focus a lot of attention on articles that deal with ways to increase vaccination rates in the United States. We do so because our vaccine rates are suboptimal for a variety of reasons, many of which are related to unsubstantiated risk. What can we do to improve vaccination rates? Europe may offer us an answer. Did you know for example that there are 7 countries in Europe that mandate vaccination and only 2 of these allow nonmedical exemptions? In addition, 6 of these 7 countries will inflict financial penalties to families who do not immunize their children. So what are the vaccination rates in these countries and what about the incidence of vaccine-preventable diseases like pertussis and measles?

Vaz et al (10.1542/peds.2019-0620) evaluated these questions in new study being early released in our journal. The authors used data from the European Centers for Disease Control and Prevention and the World Health Organization to look at European countries that do and do not mandate vaccine administration to children in regard to vaccination against measles and pertussis, as well as the annual incidence of these two diseases in these countries. The results are interesting and perhaps not exactly what you might expect. On the good side, mandatory vaccinations did result in statistically significant increases in childhood vaccination against pertussis and measles. The interesting news is that only when a country did not allow nonmedical exemptions did the mandatory vaccine policy result in a significant decrease in measles, but not for pertussis. Why?

We asked Drs. Sean O’Leary (University of Colorado) and Yvonne Maldonado (Stanford) (10.1542/peds.2019-2436) to weigh in with an accompanying commentary. They draw some interesting lessons about vaccination mandates and changes in disease burden and bring to light other important considerations related to financial penalties and vaccination mandates. One important takeaway is that vaccine policies are uniform across each specific European country instead of the patchwork that exists across states. There is a lot of great information injected into the pages of this important study—so take a shot at reading both this study and commentary and then share with parents who will hopefully be even more convinced about why vaccination should be mandatory for their child. If state legislators read this study and commentary, perhaps vaccination policy, including mandates, will be made stronger.


Copyright © 2020 American Academy of Pediatrics

Mandatory Vaccination in Europe and Epidemiology of Vaccine Preventable Diseases 

 https://pediatrics.aappublications.org/content/145/2/e20190620?utm_source=TrendMD&utm_medium=TrendMD&utm_campaign=Pediatrics_TrendMD_0

VIDEO
https://ajp.psychiatryonline.org/doi/pdfplus/10.1176/appi.ajp.2020.20030272


Vaccination Policies and Disease Incidence Across the Pond: Implications for the United State
Sean T. O’Leary and Yvonne A. Maldonado
Pediatrics February 2020, 145 (2) e20192436; 



Abbreviation:CI — confidence interval

In this issue of Pediatrics, Vaz et al report the results of their study, “Mandatory Vaccination in Europe."1 Although this study analyzed vaccination and vaccine-preventable disease trends in Europe, the policy implications are timely and relevant to US vaccination practices given the ongoing measles outbreaks in the United States and the legislative responses playing out in state capitols across the United States.

In this study, the authors examined the associations between vaccination mandate policies and subsequent vaccination coverage and measles and pertussis incidence in 29 European countries. Stated another way, the authors wanted to know if having a stricter vaccination policy resulted in higher vaccination rates and a lower incidence of 2 highly contagious vaccine-preventable diseases.

We already know that in the United States, a stricter state-based vaccination policy leads to lower rates of nonmedical exemptions2,3 and lower rates of vaccine-preventable diseases,4,5 but before the study by Vaz et al,1 these questions had not been examined among European countries. We can think of 3 main reasons this study is highly relevant to US vaccine policy: First, it demonstrates that the impact of such policies is not country specific, offering guidance to countries throughout the world on strategies to increase or maintain high vaccination rates. Second, some of the policies used in Europe are strategies that have not been tried previously in the United States and may offer US policy makers strategies to consider. Third, and most important, vaccine-preventable diseases are a worldwide problem; they know no borders, and therefore, it is in the interest of all of us to study and understand how to best achieve high vaccination coverage throughout the world. Indeed, many US measles outbreaks in the last decade have been a result of cases imported from Europe, (most recently and visibly, the Clark County outbreak in Washington state).6

To examine these questions, the authors used data from the European Centre for Disease Prevention and Control and the World Health Organization to examine the relationship between country-level vaccination policies and measles and pertussis vaccination coverage and the annual incidence of these diseases in 29 European countries. To try to assess the specific impact of the vaccination policies, the authors used regression models to examine these associations, adjusting for numerous country-level covariates likely to have an impact on vaccination coverage or disease incidence, such as education, urbanicity, income, and age of the population.

The authors found that mandatory vaccination was associated with 3.00 percentage points higher prevalence of measles vaccination (95% confidence interval [CI], 0.35–5.64) and 2.14 percentage points higher prevalence of pertussis vaccination (95% CI, 0.13–4.15) compared with countries that did not have mandatory vaccination. Mandatory vaccination was associated with decreased measles incidence in countries that did not allow nonmedical exemptions (adjusted incident rate ratio = 0.14; 95% CI, 0.05–0.36), although there was no significant association between mandatory vaccination and pertussis incidence. The authors also found that incorporating financial penalties for not vaccinating increased vaccination uptake. In countries with such policies, every €500 increase in the maximum possible penalty was associated with an increase of 0.8 percentage points for measles vaccination coverage (95% CI, 0.50–1.15; P ≤ .0001) and an increase of 1.1 percentage points for pertussis vaccination coverage (95% CI, 0.95–1.30; P ≤ .0001).

In Europe and other parts of the world, policy makers have (to varying degrees) employed financial penalties for parents who choose not to vaccinate. Policy makers in the United States have for the most part shied away from such policies. This study should make us reconsider this approach because it appears to be effective. In Hungary, for example, parents could face a financial penalty of up to ∼€1600 (∼$1800) if they fail to comply with vaccination requirements; this has resulted in high vaccination coverage and essentially no measles or pertussis cases. Importantly, these types of financial penalties may also be fair because it is clear that persons unvaccinated by parental choice place an unneeded financial burden on our health care system.79
=
PEDIATRICS COVID-19 COLLECTION
We are fast-tracking and publishing the latest research and articles related to COVID-19 for free. View the collection.

Monday, April 28, 2025

 

Every dose counts: Safeguarding the success of vaccination in Europe


Marking European Immunization Week 2025, ECDC highlights the risks of suboptimal vaccination coverage in Europe



European Centre for Disease Prevention and Control (ECDC)

Number of measles cases by age group and vaccination status, EU/EEA, 2020-2024 

image: 

For the years 2019–2023, the overall distribution of cases by age group and vaccination status followed the same pattern, with the unvaccinated population of 0–9 years and >20 years of age counting for approximately 80% of the total number of cases.

view more 

Credit: ECDC





Marking European Immunization Week (EIW) 2025, the European Centre for Disease Prevention and Control (ECDC) highlights the risks of suboptimal vaccination coverage in Europe and publishes a set of operational tools that public health authorities can use to improve vaccination acceptance and uptake. The tenfold surge of reported measles cases in the European Union and European Economic Area (EU/EEA) and the detection of vaccine-derived poliovirus in four EU/EEA countries in 2024 are two clear signals of the need to achieve and maintain high immunisation coverage to protect European populations.

Vaccines have saved millions of lives worldwide. Vaccination remains one of the most effective tools in public health, preventing diseases such as measles, polio, diphtheria and pertussis. Nevertheless, more than 35 000 people were diagnosed with measles in the EU/EEA in 2024 and 23 people – 14 of them children below five years of age – died following their measles infection.

“Thanks to vaccination we have eradicated smallpox and controlled serious diseases, such as polio, diphtheria and tetanus. The challenge for immunisation today is how to safeguard these gains. Accelerated efforts are needed to sustain high vaccination coverage. Every vaccine dose counts, and timing matters for optimal protection,” says Pamela Rendi-Wagner, Director of ECDC.

Today, ECDC releases new data [2] on the almost tenfold increase in measles infections recorded in the EU/EEA in 2024. The data demonstrate the long-term impact of declining vaccination uptake and immunity gaps: among people with known vaccination status who fell ill with measles in 2024, eight out of ten had not been immunised.

Measles can affect anyone who is unprotected – not only children, but adolescents and adults as well. More than a quarter (26%) of people diagnosed with measles in 2024 were over 14 years old.

To prevent measles outbreaks and protect populations vulnerable to the disease, at least 95% of the population eligible for vaccination should receive two doses of the measles, mumps and rubella (MMR) vaccine. However, vaccination levels in the EU/EEA still fall short of this target, with recent estimates showing that only four countries (Hungary, Malta, Portugal and Slovakia) report such coverage for both doses.

Europe needs to close existing immunisation gaps to stay healthy

ECDC estimates that around 600 000 children aged 12–23 months may have missed their full primary polio vaccination course between 2022 and 2023. Between September and December 2024, circulating vaccine-derived poliovirus type 2 was detected in sewage samples in Finland, Germany, Poland, Spain and the United Kingdom. To date, no human polio cases have been reported, and the EU/EEA continues to be polio free – but, to keep it that way, targeted catch-up campaigns and improved surveillance need to address existing vaccination gaps [3].

The evidence is clear: insufficient vaccination coverage leaves too many people vulnerable to the disease, including children who are too young to be vaccinated and people who cannot receive vaccines due to medical reasons. Protecting these groups depends on high vaccination uptake in the general population eligible for vaccination.

Successful vaccination programmes are built on understanding and responding to people’s beliefs, concerns, and expectations. Understanding the social and behavioural barriers and facilitators to vaccination is essential to design effective strategies and interventions to increase vaccination acceptance and uptake.

To support EU/EEA countries to take such action, ECDC has published the report ‘Tools and methods for promoting vaccination acceptance and uptake: a social and behavioural science approach’ [3]. The report compiles a set of operational tools in usable and adaptable formats that fit the real-life context that public health authorities work in and describe vaccination programmes that can help tailor their efforts to the specific needs and challenges of diverse communities.

In addition, the deployment of modern digitalised immunisation information systems to identify and reach people who are unvaccinated is critical and should form an integral part of national efforts to improve the performance and management of the overall national immunisation programme.

Continuous EU and national investment in high-quality surveillance and prompt outbreak investigations are key to closely monitoring the epidemiology of vaccine-preventable diseases in the EU/EEA and to identifying and addressing immunity gaps in the population.

---------ends-------

Notes to editors

[1] European Immunization Week is marked each year during the last week of April and is an important opportunity to highlight the vital role of vaccination in protecting health and well-being at every stage of life. ECDC continues to support and strengthen national immunisation programmes, with a strong focus on vaccine quality, safety, and effectiveness, while working to ensure timely and equitable access for everyone.

[2] Annual Epidemiological Report for 2024. Stockholm: ECDC; 2025. Available from 28 April 2025: https://www.ecdc.europa.eu/en/publications-data/measles-annual-epidemiological-report-2024

[3] Tools and methods for promoting vaccination acceptance and uptake: a social and behavioural science approach. Stockholm: ECDC; 2025. Available from 28 April 2025: https://www.ecdc.europa.eu/en/publications-data/tools-and-methods-promoting-vaccination-acceptance-and-uptake

[4] Join ECDC's digital EIW event bridging epidemiology and social sciences to identify, understand and find joint solutions to address barriers against vaccination, close immunity gaps and improve vaccination coverage across the EU/EEA: "Closing vaccination gaps, reaching every community, Monday, 28 April, 13:30-15:30 CEST. Register here: bit.ly/EIW2025Event  

Friday, September 26, 2025

 

Protecting the protectors: as measles cases surge, how can we help healthcare workers get vaccinated?




Frontiers





In recent years, measles has made a resurgence globally. In England, 2024 saw the highest number of confirmed measles cases since 2012, resulting in the declaration of a national incident. One reason for this is falling vaccination rates, prompted — to some extent — by the success of established measles vaccination programmes, which has reduced public awareness of the contagiousness and potentially serious complications of measles. 

Measles is often erroneously thought to be a childhood disease. Yet approximately one-third of the 2,911 cases confirmed in England in 2024, and six of the seven measles-related deaths since 2000, were in adults. Healthcare workers  are at the frontline of outbreak containment and patient care. Their occupational exposure means they are at higher risk of catching measles than the general population. However, studies across Europe have shown that concerning proportions of healthcare workers are not immune to measles, meaning they are more susceptible to infection and could spread the virus among vulnerable patient populations. Our article explored barriers and motivators to measles vaccination among a group of 23 female healthcare workers at a London hospital. 

Raising the profile of measles vaccination

The interviews showed that knowledge of measles and measles vaccination was generally low, due to a lack of personal or professional experience with measles, which did not feature prominently in participants’ healthcare training. A lack of awareness of the symptoms, contagiousness, and potential complications of measles can delay the diagnosis of infected patients and lower the perceived need for vaccination. Those who are hesitant may also choose not to be vaccinated, due to the low perceived risk of being exposed to measles and the notion that it is a childhood disease that their body will be able to fight. 

A now-discredited article published in 1998 that linked the combined measles, mumps and rubella (MMR) vaccine to autism also remains present in the minds of some healthcare workers. Almost half of the interviewees spontaneously referred to autism, although only a small number gave this as a reason for not being vaccinated or not vaccinating their children.  

In addition, there is a considerable proportion of healthcare workers who do not know their measles vaccination status (ten of the 23 participants in our study). This is not surprising, considering that measles forms part of the childhood vaccination schedule and few adults will remember receiving their childhood vaccines, meaning they rely on their parents, GP or hospital occupational health department for up-to-date vaccination records. Access may be especially difficult if healthcare workers have emigrated from their country of birth. Unsurprisingly, the idea of an app or platform where healthcare workers could easily access and manage their vaccination records was popular.

Ensuring healthcare workers are aware of their vaccination status, providing them with better training, engaging them in discussions about the risks of measles, and, importantly, the safety and effectiveness of the MMR vaccine may help to increase awareness and alleviate concerns, and is therefore an important public health priority. 

Strengthening vaccine screening

Many hospitals, including the one in our study, screen for measles vaccination as part of their pre-employment screening. This often relies on self-report or the transfer of records, but the. application of screening protocols can be inconsistent and record-keeping poor. Several participants did not recall if measles formed part of their screening or described it as a tick box exercise. There was greater awareness of hepatitis B vaccination, partly because this requires regular boosters. 

Prior research found that only 48 of 104 hospital trusts in England recorded their staff’s MMR vaccination status on a central database and 16 recorded staff eligibility for the MMR vaccine. Patient-facing healthcare workers who cannot confirm prior measles infection or vaccination with at least one dose tend to be offered vaccination with or without prior immunity testing. 

Placing more emphasis on measles vaccination alongside regular educational and awareness campaigns underlines a hospital’s commitment to, and thus emphasises the importance of, measles vaccination. While expanding immunity testing to all healthcare workers may not be financially and logistically practical for many trusts, screening protocols should ensure all patient-facing staff, including those who move from non-patient-facing to patient-facing roles within a trust, are screened and accurate records of staff vaccinations are kept.

Reframing vaccination as patient care

Healthcare workers with an uncertain vaccination status were generally positive about measles vaccination, but suggested that having to find out their status and make time for vaccination appointments constituted a barrier because of their time constraints. Several interviewees routinely prioritized patient care over what they considered personal chores. Using prompts and reminders, reframing measles vaccination as a means to protect vulnerable patients and the wider community, and action from employers to make it easier for busy healthcare workers to take time to get vaccinated would further underline the importance of measles vaccination and may help those who want to be vaccinated. 

Healthcare workers are at the frontline of our defence against resurging diseases such as measles, and it is vital that they are protected. However, if we want them to prioritize measles vaccination, hospitals and other healthcare facilities should continue to campaign for improved vaccination uptake. Improving screening processes in hospitals and holding regular educational campaigns can help to raise awareness of the risks of measles and the benefits of vaccination, and serve as a nudge for those who are unsure. 
 

 

Thursday, October 21, 2021

Canada's COVID-19 travel vaccine passport: Canadian government reveals standardized, national proof of vaccination
IT TOOK AN ELECTION TO GET THEM TO DO THIS 


Travelers wearing face masks walk out of the arrivals hall at Toronto Pearson International Airport in Mississauga, Ontario, Canada, on July 5, 2021. Starting from Monday, "fully vaccinated" Canadians and permanent residents can enter Canada without undergoing quarantine
. (Photo by Zou Zheng/Xinhua via Getty Images)


Elisabetta Bianchini
Thu, October 21, 2021, 9:26 AM·3 min read

Prime Minister Justin Trudeau announced Thursday that provincial and territorial governments across Canada will move forward with a standardized proof of COVID-19 vaccination certificate.

"All provinces and territories have confirmed that they will be moving forward with a standardized, national proof of vaccination," Trudeau said at a press conference on Thursday.

The prime minister highlighted that Saskatchewan, Ontario, Quebec, Nova Scotia, Newfoundland, Yukon, Nunavut and the Northwest Territories have put in for use of the national standard for proof of vaccination, with the remaining provinces "working hard to come online."


He added that the federal government will be "picking up the tab" for this standardized certificate.

The information on the proof of vaccination includes:


Full name and date of birth


A "neutral, factual" account COVID-19 vaccination history, including the dates of vaccination, the number of doses, vaccine type(s), product name(s) and lot number(s)


A QR code that includes the vaccination history and may include "additional information on the COVID-19 vaccines received"

The federal government has indicated that this proof of vaccination complies with the SMART Health Card standard, recognized by a number of international travel destinations.

Canada COVID-19 proof of vaccination (Government of Canada)
How to get your Canadian COVID-19 proof of vaccination?

If you live in a province or territory using a COVID-19 proof of vaccination system locally, like Ontario, you may already have the Canada COVID-19 proof of vaccination.

You have the Canadian COVID-19 proof of vaccination if the document:


Says “COVID-19 Proof of Vaccination” at the top of the document


Includes the official logos for your province or territory, the Government of Canada (the word “Canada” with the Canadian flag above the last “a”)


Has your full name and date of birth


Shows your COVID-19 vaccination history, including the number of dose(s), the vaccine type(s), product name(s) and lot number, the date(s) you got your vaccination(s), a SMART Health Cards QR code


Is a bilingual document

This proof of vaccination document can be accessed as a file on a mobile device, computer or mobile wallet, or printed.

While the federal government highlights that "many international destinations may accept the Canadian COVID-19 proof of vaccination," it is also stressed that "each destination makes the final decision on what they accept as proof of vaccination."

"There are many different standards being looked at around the world, Europe has one, we are using the SMART Health Card format that many places in the United States and elsewhere around the world are using," Trudeau said.

"We are very confident that this proof of vaccination certificate, that will be federally approved, issued by the provinces, with the health information for Canadians, is going to be accepted at destinations worldwide as proof of vaccination."

For Canadians returning to Canada, their proof of vaccination document can be uploaded to the ArriveCAN app up to 72 hours before arrival in the country.
Mixed COVID-19 vaccine doses

As of Nov. 8, Canadians vaccinated with any combination of authorized COVID-19 vaccines will be considered fully vaccinated by the U.S. government.

"The Government of Canada is actively engaging other countries and international partners to encourage them to recognize those who have received mixed vaccine schedules or extended dose intervals as being fully vaccinated," information from the Canadian government reads.

"Initial outreach has focused on the ongoing exchange of technical and scientific information to advance this time-sensitive work."
Travel within Canada

Effective Oct. 30, individuals travelling within Canada, age 12 and older, need to show proof of vaccination to board a plane, train or cruise ship.

This includes air passengers flying on domestic, transborder or international flights departing from airports in Canada, rail passengers on VIA Rail and Rocky Mountaineer trains, and marine passengers on non-essential passenger vessels, including cruise ships on voyages of 24 hours or more.

There will be a transition period where travellers will be able to go on their journey if they show a valid COVID-19 molecular test within 72 hours of travel, until Nov. 30.

Wednesday, September 14, 2022

Current vaccine approach not enough to eradicate measles

New study models the feasibility of eliminating measles and rubella

Peer-Reviewed Publication

UNIVERSITY OF GEORGIA

Current vaccination strategies are unlikely to eliminate measles, according to a new study led by faculty at the University of Georgia. 

The paper, which published today in The Lancet Global Health, explores the feasibility of eliminating measles and rubella using predominant vaccination strategies in 93 countries with the highest disease burden.

Despite marked reductions in the number of new measles and rubella cases worldwide, gaps remain between current levels of transmission and disease elimination. 

“Measles is one of the most contagious respiratory infections out there, and it moves quickly, so it’s hard to control,” said lead author Amy Winter, an assistant professor of epidemiology and biostatistics at UGA’s College of Public Health. 

The basic reproduction number (R0) for measles, which represents the number of people that one infected person is likely to transmit that disease to in a fully susceptible population, is roughly 18. By comparison the R0 for the original SARS-CoV-2 virus is estimated to be around three.

In 2017, the World Health Organization director general requested a report on the feasibility of measles and rubella eradication. One component of this report was to use transmission models to evaluate the theoretical feasibility of eradication of the two viruses given different vaccination strategies.

The assessment was a collaboration with the WHO Strategic Advisory Group of Experts Measles and Rubella Working Group, the World Health Organization, the U.S. Centers for Disease Control and Prevention, and five modeling groups.

Using four national disease transmission models and one sub-national model, the modeling groups projected the annual case rates for measles and rubella for two vaccination scenarios.

Both vaccination scenarios use the two predominant vaccination approaches of routine vaccination as part of childhood immunization schedules and nationwide vaccination campaigns.

The first “business as usual” vaccination scenario continues vaccination coverage and campaigns into the future. The second “intensified investment” vaccination scenario optimally improved vaccination coverage over time. This scenario also included vaccination campaign cessation criteria – a stopping point for when campaigns are no longer deemed necessary because a large enough proportion of the population has been inoculated.

The models show that current vaccine strategies could eliminate rubella and congenital rubella syndrome in all 93 counties, but not measles. 

“The current strategy that we use, which is focused on improving routine vaccination coverage and supplementing it with nationwide vaccination campaigns until routine vaccination is high enough, that alone is not going to be sufficient to reach measles elimination. We need novel approaches,” said Winter. 

The authors evaluated two strategies that could help move a country to elimination faster and reduce the probability of measles outbreaks: One, improve how supplemental vaccine campaigns are delivered to ensure they are reaching children who are not receiving routine vaccinations.

Two, improve vaccine coverage equity by focusing routine and supplemental vaccination on sub-regions with the lowest vaccination coverage first to get them up to par.

“A world that is permanently free of measles and rubella would be an incredible achievement for humanity. Our work suggests that to reach this goal, we need to make vaccine coverage much more equal,” said co-author Mark Jit, professor of vaccine epidemiology at the London School of Hygiene & Tropical Medicine.

“In other words, we need to work even harder to bring measles and rubella vaccination to the most underserved people around the world.”

The final strategy the authors present is a reconsideration of cessation criteria. Currently, most countries stop supplementing routine vaccines with vaccination campaigns once they reach elimination status, said Winter, but the models suggest that outbreaks are still likely to occur if countries rely on routine vaccines alone.

It’s critical, Winter warns, to remain vigilant to surveil for rubella and measles cases and rapidly respond to potential outbreaks even after elimination is achieved.

“We have a globally connected world, so there’s this constant pressure of importations of the viruses in places where it’s already eliminated,” she said. “That’s why keeping vaccination coverage high and continuing to improve surveillance for these diseases is important.”

Friday, October 22, 2021

Parents were fine with sweeping school vaccination mandates five decades ago – but COVID-19 may be a different story


James Colgrove, Professor of Sociomedical Sciences, Mailman School of Public Health; Dean of the Postbaccalaureate Premedical Program, Columbia School of General Studies, Columbia University

Fri, October 22, 2021

Children and parents lined up for polio vaccines outside a Syracuse, New York school in 1961. AP Photo

The ongoing battles over COVID-19 vaccination in the U.S. are likely to get more heated when the Food and Drug Administration authorizes emergency use of a vaccine for children ages 5 to 11, expected later this fall.

California has announced it will require the vaccine for elementary school attendance once it receives full FDA approval after emergency use authorization, and other states may follow suit. COVID-19 vaccination mandates in workplaces and colleges have sparked controversy, and the possibility that a mandate might extend to younger children is even more contentious.

Kids are already required to get a host of other vaccines to attend school. School vaccination mandates have been around since the 19th century, and they became a fixture in all 50 states in the 1970s. Vaccine requirements are among the most effective means of controlling infectious diseases, but they’re currently under attack by small but vocal minorities of parents who consider them unacceptable intrusions on parental rights.

As a public health historian who studies the evolution of vaccination policies, I see stark differences between the current debates over COVID-19 vaccination and the public response to previous mandates.
Compulsory vaccination in the past

The first legal requirements for vaccination date to the early 1800s, when gruesome and deadly diseases routinely terrorized communities. A loose patchwork of local and state laws were enacted to stop epidemics of smallpox, the era’s only vaccine-preventable disease.

Vaccine mandates initially applied to the general population. But in the 1850s, as universal public education became more common, people recognized that schoolhouses were likely sites for the spread of disease. Some states and localities began enacting laws tying school attendance to vaccination. The smallpox vaccine was crude by today’s standards, and concerns about its safety led to numerous lawsuits over mandates.

The U.S. Supreme Court upheld compulsory vaccination in two decisions. The first, in 1905, affirmed that mandates are constitutional. The second, in 1922, specifically upheld school-based requirements. In spite of these rulings, many states lacked a smallpox vaccination law, and some states that did have one failed to enforce it consistently. Few states updated their laws as new vaccines became available.

School vaccination laws underwent a major overhaul beginning in the 1960s, when health officials grew frustrated that outbreaks of measles were continuing to occur in schools even though a safe and effective vaccine had recently been licensed.

Many parents mistakenly believed that measles was an annoying but mild disease from which most kids quickly recovered. In fact, it often caused serious complications, including potentially fatal pneumonia and swelling of the brain.

With encouragement from the Centers for Disease Control and Prevention, all states updated old laws or enacted new ones, which generally covered all seven childhood vaccines that had been developed by that time: diphtheria, pertussis, tetanus, polio, measles, mumps and rubella. In 1968, just half the states had school vaccination requirements; by 1981, all states did.

Smiling boy rolls up his sleeve to get a shot from a nurse

Expanding requirements, mid-20th century

What is most surprising about this major expansion of vaccination mandates is how little controversy it provoked.

The laws did draw scattered court challenges, usually over the question of exemptions – which children, if any, should be allowed to opt out. These lawsuits were often brought by chiropractors and other adherents of alternative medicine. In most instances, courts turned away these challenges.

There was scant public protest. In contrast to today’s vocal and well-networked anti-vaccination activists, organized resistance to vaccination remained on the fringes in the 1970s, the period when these school vaccine mandates were largely passed. Unlike today, when fraudulent theories of vaccine-related harm – such as the discredited notion that vaccines cause autism – circulate endlessly on social media, public discussion of the alleged or actual risks of vaccines was largely absent.

Through most of the 20th century, parents were less likely to question pediatricians’ recommendations than they are today. In contrast to the empowered “patient/consumer” of today, an attitude of “doctor knows best” prevailed. All these factors contributed to overwhelmingly positive views of vaccination, with more than 90% of parents in a 1978 poll reporting that they would vaccinate their children even if there were no law requiring them to do so.

Widespread public support for vaccination enabled the laws to be passed easily – but it took more than placing a law on the books to control disease. Vaccination rates continued to lag in the 1970s, not because of opposition, but because of complacency.

Thanks to the success of earlier vaccination programs, most parents of young children lacked firsthand experience with the suffering and death that diseases like polio or whooping cough had caused in previous eras. But public health officials recognized that those diseases were far from eradicated and would continue to threaten children unless higher rates of vaccination were reached. Vaccines were already becoming a victim of their success. The better they worked, the more people thought they were no longer needed.

In response to this lack of urgency, the CDC launched a nationwide push in 1977 to help states enforce the laws they had recently enacted. Around the country, health officials partnered with school districts to audit student records and provide on-site vaccination programs. When push came to shove, they would exclude unvaccinated children from school until they completed the necessary shots.

The lesson learned was that making a law successful requires ongoing effort and commitment – and continually reminding parents about the value of vaccines in keeping schools and entire communities healthy.
Add COVID-19 to vaccine list for school?

Five decades after school mandates became universal in the U.S., support for them remains strong overall. But misinformation spread over the internet and social media has weakened the public consensus about the value of vaccination that allowed these laws to be enacted.


adults and kids with signs protesting COVID-19 vaccines

COVID-19 vaccination has become politicized in a way that is unprecedented, with sharp partisan divides over whether COVID-19 is really a threat, and whether the guidance of scientific experts can be trusted. The attention focused on COVID-19 vaccines has given new opportunities for anti-vaccination conspiracy theories to reach wide audiences.

[Over 115,000 readers rely on The Conversation’s newsletter to understand the world. Sign up today.]

Fierce opposition to COVID-19 vaccination, powered by anti-government sentiment and misguided notions of freedom, could undermine support for time-tested school requirements that have protected communities for decades. Although vaccinating school-aged children will be critical to controlling COVID-19, lawmakers will need to proceed with caution.

This article is republished from The Conversation, a nonprofit news site dedicated to sharing ideas from academic experts. It was written by: James Colgrove, Columbia University.

Read more:

Half of unvaccinated workers say they’d rather quit than get a shot – but real-world data suggest few are following through

Shutting down school vaccine clinics doesn’t protect minors – it hurts people who are already disadvantaged

James Colgrove has received funding from the National Library of Medicine, the Greenwall Foundation, the Milbank Memorial Fund, and the William T. Grant Foundation.

Thursday, October 09, 2025

 

Drop in childhood vaccination coverage: Dutch study identifies trends driven by socioeconomic factors




Vaccination coverage among Dutch children born between 2008-2020 against measles, mumps, rubella and diphtheria–tetanus–pertussis–poliomyelitis declined faster among e.g. children not attending daycare or from households with lower income.




European Centre for Disease Prevention and Control (ECDC)





In the Netherlands, the National Immunisation Programme (NIP) was established in 1957. This programme provides free and voluntary vaccinations against 13 serious infectious diseases and has drastically reduced child and young adult mortality across the country. However, recent trends show a decline in vaccination coverage, particularly for the diphtheria and tetanus toxoids and acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) and measles, mumps and rubella (MMR) vaccines. While 95% of Dutch children born between 2008─-2010 received vaccines against MMR and DTaP, coverage dropped successively over the years, and only 88─-89% of children born in the Netherlands in 2020 got vaccinated.

In their study published in Eurosurveillance, Pijpers et. al, identified several sociodemographic factors contributing to the observed decline in vaccination rates, including lower parental education, income, and migration background of parents. The retrospective cohort study used several data sources looking at more than 2,3 million children born between 2008 and 2020, a total of 2,323,838 children for MMR and 2,331,199 for DTaP-IPV. [1]

By the age of two years, 94% of children (2,174,229) had received the MMR vaccine, and 93% (2,172,402) had received the DTaP-IPV vaccine. Among the 2,319,001 children eligible for both vaccines, 97% had matching vaccination status. This meant they either received both vaccines or neither. Meanwhile, 1.4% were vaccinated only for MMR, and 1.3% only for DTaP-IPV [1].

General decline in vaccination coverage in the Netherlands reflects broader European trends
Coverage for the first dose of measles-containing vaccine in the EU/European Economic Area (EEA) decreased from 95% in 2018 to 92% in 2022 [2]. Common explanations for declining coverage include distrust in vaccines and governmental organisations, misinformation, and the influence of social media. These issues were reportedly exacerbated during the COVID-19 pandemic. 

As outlined in this study, in 2022, in the Netherlands, trust in governmental institutions was below pre-pandemic levels, especially among individuals with lower maternal education levels, and was associated with lower COVID-19 vaccine uptake [3]. Parental perceptions of childhood vaccination also became slightly more negative after the pandemic, although the decline in the coverage had already begun earlier. 

Social media was seen to play a significant role in spreading misinformation regarding vaccination. Research on Dutch Twitter activity in 2019 showed how anti-vaccine narratives gained traction and influenced public opinion. Selective exposure to this type of content reinforces negative attitudes, and the unregulated nature of online anti-vaccine messaging increases the risk of uninformed decision making.

Decline in vaccination coverage more pronounced in specific population groups
The most substantial declines in vaccination rates for MMR and DTaP-IPV were observed among Dutch children of non-Dutch origin, children not attending daycare, those with self-employed mothers, and children in the lowest income households [1]. According to the study results, children of Moroccan, Turkish, Dutch-Caribbean, and Surinamese origin showed notably lower vaccination coverage. 

Qualitative studies have provided further insight into the reasons behind lower vaccination coverage among Dutch children with a migration background. As outlined in this study, results of a focus group in 2015 among parents of Moroccan and Turkish origin identified barriers such as difficulty understanding NIP information, limited consultation time, and challenges accessing vaccination centres.

Children not attending daycare also showed lower vaccination coverage. Vaccination is not required for daycare attendance in the Netherlands. Nevertheless, in these settings, parents are often asked about their child’s vaccination status which was seen to potentially influence their vaccination decision making. Given the close contact among children in daycare settings, higher vaccination coverage in these environments would be beneficial for preventing future outbreaks. 

Children from larger families (four or more children) had lower vaccination coverage than those from smaller families. This may be explained, in part, by the higher prevalence of large households within Orthodox Protestant communities, where vaccine hesitancy is more common. While lower income was historically associated with larger family size, recent trends suggest that higher income is becoming an increasingly important factor for having more children, particularly among mothers.

As outlined in this paper, systematic reviews have consistently found lower routine childhood vaccination coverage among children with lower parental socioeconomic status. In high-income countries, economic disparities in vaccine uptake are often linked to perceived risks, trust in government and healthcare professionals, and vaccine confidence, rather than financial access. 

Addressing the decline in childhood vaccination: A call for targeted action
The findings in this paper highlight not only a general downward trend in vaccination uptake but also widening disparities among sociodemographic groups, with children of non-Dutch origin, those from lower-income households, and those not attending daycare being disproportionately affected. These patterns increase the risk of localised outbreaks, especially where unvaccinated children are socially clustered. 

Pijpers et. al. state that “social clustering potentially creates environments where infections spread more easily. Therefore, further research to investigate networks of unvaccinated and nonimmune individuals is needed to assess the risk of spread of vaccine-preventable diseases.”.

As this paper outlines, further research is needed to understand the underlying causes affecting vaccine uptake among lower socioeconomic groups. Addressing misinformation, rebuilding trust in public institutions, and ensuring equitable access to vaccination services will be critical to reversing these trends and safeguarding children's health across all segments of society.


----Ends----
References/notes to editors:
[1]  Pijpers Joyce, van Roon Annika, Schipper Maarten, Stok Marijn, van den Hof Susan, van Gaalen Ruben, Hahné Susan, de Melker Hester. The decrease in childhood vaccination coverage and its sociodemographic determinants, the Netherlands, birth cohorts 2008 to 2020. Euro Surveill. 2025;30(39):pii=2500251. Available from https://doi.org/10.2807/1560-7917.ES.2025.30.39.2500251

[2] European Centre for Disease Prevention and Control (ECDC). Threat assessment brief: Measles on the rise in the EU/EEA: considerations for public health response. Stockholm: ECDC; 2024. Available from: https://www.ecdc.europa.eu/en/publications-data/threat-assessment-brief-measles-rise-eueea-considerations-public-health-response
 
[3] Derksen E, Janssen L, Tummers-van der Aa M. COVID-19-vaccinatiegedrag. [COVID-19 vaccination behaviour]. The Hague: Centraal Bureau voor de Statistiek; 2023. Dutch. Available from: https://www.cbs.nl/nl-nl/longread/rapportages/2023/covid-19-vaccinatiegedrag